Arxada published a German review article detailing the first synthesis of 7-Fluoroellipticine.
Published
Signal category
Research & Knowledge
Quote
“A German review article details the FIRST synthesis of 7-Fluoroellipticine”
— Dr. Grahame N. Taylor|Arxada team
Company
Arxada
Arxada is a global specialty chemicals business creating innovative solutions that protect our world.
- Industry
- Chemical Manufacturing
- Location
- Basel, CH
- Company size
- 1,485 employees
Arxada is a global leader in innovative solutions that protect our world. Our groundbreaking technologies, in-depth regulatory know-how, manufacturing and process development help our customers to safeguard nutrition, health and infrastructure efficiently through chemistry and biotechnology that enhance sustainability. We offer a broad portfolio of ingredients and services for multiple end-markets that include Human Health & Nutrition, Home & Personal Care, Professional Hygiene, Paints & Coatings and Wood Protection. With customers in more than 100 countries, the company achieved sales of CHF 2 billion in 2024. Headquartered in Basel (Switzerland), Arxada employs 3,200 associates across 24 production sites and 14 R&D centers, all committed to our customers’ success. Arxada is held by Herens Midco S.à r.l
Founded 2021